Hirohata S, Kamoshita H, Taketani T, Maeda S
Arch Intern Med. 1986 Dec;146(12):2409-10.
A 65-year-old woman with adult Still's disease developed adult respiratory distress syndrome (ARDS), a fatal pulmonary complication. Intravenous administration of cyclophosphamide, 500 mg/d for three days, was much more effective than high doses of corticosteroids in the patient. Interestingly, hypersensitivity to flavoxate hydrochloride seemed to be a precipitating factor, but not a cause, for both a series of characteristic manifestations of adult Still's disease and development of ARDS in our patient. The association of ARDS with adult Still's disease has not yet been reported. Physicians should be aware of this fatal complication in adult Still's disease, especially in the presence of drug hypersensitivities.
一名65岁患有成人斯蒂尔病的女性发生了成人呼吸窘迫综合征(ARDS),这是一种致命的肺部并发症。静脉注射环磷酰胺,500毫克/天,连用三天,对该患者的疗效远优于高剂量皮质类固醇。有趣的是,对盐酸黄酮哌酯的超敏反应似乎是我们患者成人斯蒂尔病一系列特征性表现及ARDS发生的一个促发因素,但并非病因。ARDS与成人斯蒂尔病的关联尚未见报道。医生应意识到成人斯蒂尔病中这种致命并发症,尤其是在存在药物超敏反应的情况下。